Table 2.
Laboratory parameters of patients included in the study.
| Number of patients with data available | ||
|---|---|---|
| Median (Q1-Q3) white blood cells (WBC) at admission (cells/uL) | 269 | 7900(6100–10700) |
| Mean (SD) International Normalized Ratio (INR) at admission | 230 | 1.10(0.29) |
| Median (Q1-Q3) Blood creatinine at admission (mg/dl) | 266 | 0.9(0.75–1.17) |
| Median (Q1-Q3) creatine phosphokinase (CPK) at admission (U/L) | 148 | 100.5(54–189.5) |
| Median (Q1-Q3) lactate dehydrogenase (LDH) at admission (U/I) | 243 | 347(267–461) |
| Median (Q1-Q3) PaO2/FiO2 Ratio (P/F) at admission | 273 | 164(115–251) |
| Median (Q1-Q3) ALT at admission (U/L) | 242 | 32(22–52) |
| Median (Q1-Q3) AST at admission (U/L) | 262 | 36.5(25–50) |
| Median (Q1-Q3) Bilirubin at admission(mg/dl) | 204 | 0.64(0.495–0.975) |
| Median (Q1-Q3) procalcitonin at admission (ng/ml) | 162 | 0.09(0.05–0.24) |